variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
RYR2-G1886S,RYR2,"Reported to cause arrhythmogenic right ventricular cardiomyopathy when compound heterozygous with G1885E, although this finding is weakened after correcting for multiple hypotheses and it is unclear what penetrance such a genotype might have, if it is causal.",High,Uncertain,Pathogenic,0.061,"Heart and circulatory;Muscular, skeletal, and connective tissue;Nervous system",Recessive,Heterozygous,16769042;18326664,rs3766871,4,chr1,237778084,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
C7-R521S,C7,"Reported to cause complement component 7 deficiency in a recessive manner, increasing susceptibility to systemic infections. This report is recorded in ClinVar by OMIM (http://www.ncbi.nlm.nih.gov/clinvar/RCV000012887/).",Moderate,Uncertain,Pathogenic,,Other,Recessive,Heterozygous,,,5,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
PPARG-P12A,PPARG,,Moderate,Uncertain,Not Reviewed,0.089,Other,Unknown,Heterozygous,16783862;17213274;17463248,rs1801282,3,chr3,12393125,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Homozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
MBL2-G54D,MBL2,"This variant is associated with mannose binding protein deficiency which leads to impaired complement system immune response to mannose-rich pathogens. Patients homozygous for this allele or compound heterozygous are likely to have increased susceptibility to infection, but Hellemann et al. report heterosis for intensive care outcomes in heterozygous subjects. The wild-type version of this gene is known as variant allele A, while this is called variant allele B. See R52C (variant D) and G57E (variant C).",Low,Likely,Pathogenic,0.1,Immune system,Recessive,Heterozygous,7564730;10199352;17872904,rs1800450,3,chr10,54531235,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
TLR5-R392X,TLR5,"This variant is believed to impair the ability to generate an immune response to the flagella of the bacteria. It is weakly associated with an increased incidence of Legionnaires' Disease, p = 0.085, increased lifetime risk of disease ~0.88% (about twice average). The variant is also weakly associated with a reduced incidence of systemic lupus erythematosus, p = 0.165.",Low,Uncertain,Pathogenic,0.044,Immune system,Complex/Other,Heterozygous,14623910;16027372;17516623;18230059,rs5744168,1,chr1,223285200,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Heterozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
SLC5A2-N654S,SLC5A2,"Some authors report this rare variant as a nonpathogenic polymorphism, others suggest it may cause renal glucosuria in a recessive manner when compound heterozygous with other pathogenic variants.",Low,Uncertain,Pathogenic,0.0071,Genital and urinary,Recessive,Heterozygous,14569097;14614622;15110322;18622023,rs61742739,5,chr16,31501798,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
CLEC7A-Y238X,CLEC7A,This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.,Low,Uncertain,Pathogenic,0.063,Genital and urinary;Skin,Recessive,Heterozygous,19864674,rs16910526,4,chr12,10271087,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Heterozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Homozygous,,rs1544410,0,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
ABCG5-R50C,ABCG5,This variant has a mild protective effect on blood cholesterol. It is associated with slightly lower total and LDL cholesterol levels.,Low,Likely,Protective,0.068,Blood;Metabolism,Unknown,Heterozygous,19060911,rs6756629,1,chr2,44065090,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Heterozygous,,rs12742169,,chr1,201052310,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
FBN2-S2580L,FBN2,"Probably benign -- initially associated with congenital contractual arachnodactyly, but later reports classify it as a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.078,Anatomical and congenital,Dominant,Heterozygous,9714438;10633129;16835936;17345643,rs2291628,,chr5,127609633,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
RPGRIP1-A547S,RPGRIP1,"Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.",Low,Uncertain,Benign,0.23,Hearing and vision,Complex/Other,Heterozygous,12920076;16272259,rs10151259,,chr14,21790040,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
AARS-K967M,AARS,Tentatively presumed benign because seen in a healthy PGP participant. A damaging effect to the gene is predicted by Polyphen 2 and other variants are reported to cause Chacot-Marie-Tooth neuropathy in a dominant manner.,Low,Uncertain,Benign,0.011,Nervous system,Unknown,Homozygous,20045102,rs35744709,,chr16,70286631,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
FLG-H2463D,FLG,"Tentatively evaluated as benign. Other, much more severe null mutations cause increased susceptibility ichthyosis vulgaris, atopic eczema, and allergies.",Low,Uncertain,Benign,0.0065,Immune system;Skin,Unknown,Heterozygous,,rs113188294,,chr1,152279975,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
COL5A2-P460S,COL5A2,"Tentatively benign. Although predicted to be damaging by Polyphen 2, this variant is seen in 2 out of 62 PGP & public genomes. OMIM lists other more disruptive variants (frameshift & nonsense) as reported to cause Ehlers-Danlos syndrome when homozygous.",Low,Uncertain,Benign,0.04,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,,rs35830636,,chr2,189932764,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
PCCA-I475V,PCCA,"Reported as a polymorphism, tentatively presumed benign.",Low,Uncertain,Benign,0.038,Other,Unknown,Heterozygous,10101253,rs35719359,,chr13,100962156,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
NSD1-A2546T,NSD1,"Benign, reported as a polymorphism.",Low,Uncertain,Benign,0.025,Other,Unknown,Heterozygous,14571271;15720303,rs78247455,,chr5,176722005,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f903c21bb73d0c516912f195c0eb197a74307cfc&access_token=9565b3ff050cd8a3b491311774bc7e20
